PATENT CLAIM ANALYSIS

Application Number: 15774962
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["560", "008000"]

Abstract:
Disclosed are small molecule inhibitors of mammalian target of rapamycin (mTOR), and methods of using them.

Claim (Index 1):
A compound of Formula (I) or a pharmaceutically acceptable salt thereof: wherein: Y 1  and Y 2  are independently NH, O, or S; L 1  and L 2  are independently C 2 -C 8  alkylene or C 2 -C 8  alkenylene; R x  is, independently for each occurrence, C 3 -C 6  branched alkyl; R y  is alkyl, aralkyl, cycloalkyl, or cycloalkylalkyl; R z  is nitro or arylsulfonyl; Z 1  is \u2014H, NH 2 , Z 2  is n is 1, 2, or 3: m is 1, 2, or 3.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 93.0
- Lexical Diversity: 1.11111
- Patent Class: 560.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14731778', '15455727', '12631116', '13370682', '13520472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7086863093315494
- 35 USC 102 Novelty (BERT): 0.5445830303937442
- Combined Prediction Score: 0.6922759814377689
- Mean Citation Score: 251.368558
- Max Citation Score: 271.15683
- Similarity Product: 183.95543866922915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test